All Circulars (28174)
Browse all regulatory circulars from India’s major stock exchanges and market regulator. Navigate by source using the buttons below or explore individual circulars in the grid.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RTI appeal by Shamo Devi seeking information about PACL refund calculation and pending amount. SEBI Appellate Authority upholds respondent's … | |||||||||||||||
RTI appeal by Shamo Devi seeking information about PACL refund calculation and pending amount. SEBI Appellate Authority upholds respondent's response that information is not available with SEBI.
| |||||||||||||||
SEBI announces PaRRVA will begin regular operations from May 4, 2026, enabling regulated entities to showcase verified performance in … | |||||||||||||||
SEBI announces PaRRVA will begin regular operations from May 4, 2026, enabling regulated entities to showcase verified performance in investment advisory, research services, and algorithmic trading.
| |||||||||||||||
SEBI issues release order for Recovery Certificate No. 8737 of 2025 against 3M Team Research Private Limited, Rakesh Sethi, and Pramod Jain … | |||||||||||||||
SEBI issues release order for Recovery Certificate No. 8737 of 2025 against 3M Team Research Private Limited, Rakesh Sethi, and Pramod Jain in the matter of unregistered Portfolio Management Service.
| |||||||||||||||
SEBI issues a release order for Recovery Certificate No. 8738 of 2025 against 3M Team Research Private Limited, Rakesh Sethi, and Pramod … | |||||||||||||||
SEBI issues a release order for Recovery Certificate No. 8738 of 2025 against 3M Team Research Private Limited, Rakesh Sethi, and Pramod Jain in the matter of unregistered portfolio management services.
| |||||||||||||||
BSE/ICCL notice detailing the settlement schedule for the Offer to Buy acquisition window under the buyback program for Windlas Biotech … | |||||||||||||||
BSE/ICCL notice detailing the settlement schedule for the Offer to Buy acquisition window under the buyback program for Windlas Biotech Limited.
| |||||||||||||||
BSE notice applying minimum 35% margin requirement in Equity and Equity Derivatives segments for securities with high promoter encumbrance … | |||||||||||||||
BSE notice applying minimum 35% margin requirement in Equity and Equity Derivatives segments for securities with high promoter encumbrance effective May 5, 2026, with some securities exiting the framework from April 30, 2026.
| |||||||||||||||
BSE places additional securities under the Additional Surveillance Measure framework for companies undergoing Insolvency Resolution Process … | |||||||||||||||
BSE places additional securities under the Additional Surveillance Measure framework for companies undergoing Insolvency Resolution Process (IRP) under IBC, effective April 30, 2026, while certain securities are removed from the framework.
| |||||||||||||||
NSE notifies suspension of trading in 9 privately placed non-convertible securities across 4 companies effective April 30, 2026, due to … | |||||||||||||||
NSE notifies suspension of trading in 9 privately placed non-convertible securities across 4 companies effective April 30, 2026, due to redemption. Affected issuers include SMFG India Home Finance, Shillong Jorabat Expressway, Power Grid Corporation, and HDFC Bank.
| |||||||||||||||
BSE notifies suspension of trading in Sovereign Gold Bond 2019 Series (ISIN: IN0020180033, Scrip Code: 800287) with effect from April 30, … | |||||||||||||||
BSE notifies suspension of trading in Sovereign Gold Bond 2019 Series (ISIN: IN0020180033, Scrip Code: 800287) with effect from April 30, 2026, as the security reaches its redemption date.
| |||||||||||||||
BSE notifies trading members of scheduled visits by Registrar and Transfer Agent representatives to the Department of Investor Services … | |||||||||||||||
BSE notifies trading members of scheduled visits by Registrar and Transfer Agent representatives to the Department of Investor Services during May 2026 for handling investor complaints.
| |||||||||||||||